How I treat HHV8/KSHV-related diseases in posttransplant patients

Blood

Volumn 120, Issue 20, 2012, Pages 4150-4159

  Riva, Giovanni ^a   Luppi, Mario ^a   Barozzi, Patrizia ^a   Forghieri, Fabio ^a   Potenza, Leonardo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; FOSCARNET; GANCICLOVIR; INTERLEUKIN 6; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; TOCILIZUMAB; VALGANCICLOVIR; VINCRISTINE;

ACUTE HEPATITIS; ANEMIA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GRAFT REJECTION; HEMOLYTIC ANEMIA; HEPATOSPLENOMEGALY; HUMAN; HUMAN HERPESVIRUS 8; HYPERTRANSAMINASEMIA; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; IMMUNOLOGICAL MONITORING; KAPOSI SARCOMA; LYMPH NODE HYPERPLASIA; MULTIPLE ORGAN FAILURE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIMARY INFECTION; PRIORITY JOURNAL; RASH; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; SPINDLE CELL; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA; VIREMIA; VIRUS REPLICATION;

EID: 84869808044     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-421412     Document Type: Review

References (101)

1. Heslop HE. How I treat EBV lymphoproliferation. Blood. 2009;114(19):4002-4008.
2. Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIV-associated lymphomas and gamma-herpesviruses. Blood. 2009;113(6):1213-1224.
3. Bower M. How I treat HIV-associated multicentric Castleman disease. Blood. 2010;116(22):4415-4421.
4. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004;350(13):1328-1337. (Pubitemid 38375368)
5. Riva G, Barozzi P, Torelli G, Luppi M. Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias. AIDS Rev. 2010;12(1):40-51.
6. Schulz TF. The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol. 2006;208(2):187-198. (Pubitemid 43126112)
7. Ariza-Heredia EJ, Razonable RR. Human herpes virus 8 in solid organ transplantation. Transplantation. 2011;92(8):837-844.
8. Luppi M, Barozzi P, Santagostino G, et al. Molecular evidence of organ-related transmission of Kaposi's sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patient. Blood. 2000;96(9):3279-3281.
9. Sarid R, Pizov G, Rubinger D, et al. Detection of human herpesvirus-8 DNA in kidney allografts prior to the development of Kaposi's sarcoma. Clin Infect Dis. 2001;32(10):1502-1505. (Pubitemid 32424288)
10. Barozzi P, Bosco R, Vallerini D, et al. KSHV/HHV-8 infection of tubular epithelial cells in transplantation kidney. Transplantation. 2006;82(6):851-852. (Pubitemid 44470393)
11. Barozzi P, Luppi M, Facchetti F, et al. Posttransplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med. 2003;9(5):554-561. (Pubitemid 36597101)
12. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000;342(14):1027- 1038. (Pubitemid 30180651)
13. Penn I. Kaposi's sarcoma in transplant recipients. Transplantation. 1997;64(5):669-673. (Pubitemid 27407090)
14. Siegel JH, Janis R, Alper JC, Schutte H, Robbins L, Blaufox DM. Disseminated visceral Kaposi's sarcoma: appearance after human renal homograft operation. JAMA. 1969;207(8):1493-1496.
15. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266(5192):1865-1869.
16. Parravicini C, Olsen SJ, Capra M, et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patient. Blood. 1997;90(7):2826-2829. (Pubitemid 27413494)
17. Regamey N, Tamm M, Wernli M, et al. Transmission of human herpesvirus 8 infection from renal transplant donors to recipient. N Engl J Med. 1998;339(19):1358-1363.
18. Lee PC, Wang YW, Su IJ, Lin YJ, Lei HY. Immunosuppressive drugs and HHV-8 in a patient with a renal transplant and Kaposi's sarcoma. Lancet. 1998;351(9110):1175-1176.
19. Francès C, Mouquet C, Calvez V. Human herpesvirus 8 and renal transplantation. N Engl J Med. 1999;340(13):1045.
20. Rabkin CS, Shepherd FA, Wade JA. Human herpesvirus 8 and renal transplantation. N Engl J Med. 1999;340(13):1045-1046.
21. Farge D, Lebbé C, Marjanovic Z, et al. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients: Groupe Cooperatif de Transplantation d'Ile de France (GCIF). Transplantation. 1999;67(9):1236-1242. (Pubitemid 29239474)
22. Mendez JC, Procop GW, Espy MJ, Smith TF, McGregor CG, Paya CV. Relationship of HHV-8 replication and Kaposi's Sarcoma after solid organ transplantation. Transplantation. 1999;67(8):1200-1201. (Pubitemid 29205589)
23. Sachsenberg-Studer EM, Dobrynski N, Sheldon J, et al. Human herpes-virus 8 seropositive patient with skin and graft Kaposi's sarcoma after lung transplantation. J Am Acad Dermatol. 1999;40(2):308-311. (Pubitemid 29076086)
24. Francès C, Mouquet C, Marcelin AG, et al. Outcome of kidney transplant recipients with previous human herpesvirus-8 infection. Transplantation. 2000;69(9):1776-1779. (Pubitemid 30340333)
25. Cattani P, Capuano M, Graffeo R, et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol. 2001;39(2):506-508. (Pubitemid 32150808)
26. Andreoni M, Goletti D, Pezzotti P, et al. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipient. J Infect. 2001;43(3):195-199. (Pubitemid 34211102)
27. Emond JP, Marcelin AG, Dorent R, et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients. J Clin Microbiol. 2002;40(6):2217-2219. (Pubitemid 34596410)
28. Munoz P, Alvarez P, de Ory F, Pozo F, Rivera M, Bouza E. Incidence and clinical characteristics of Kaposi sarcoma after solid organ transplantation in Spain: importance of seroconversion against HHV-8. Medicine (Baltimore). 2002;81(4):293-304. (Pubitemid 34755938)
29. Barete S, Calvez V, Mouquet C, et al. Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients. Arch Dermatol. 2000;136(12):1452-1458. (Pubitemid 32009266)
30. Zmonarski SC, Boratynska M, Puziewicz- Zmonarska A, Kazimierczak K, Klinger M. Kaposi's sarcoma in renal transplant recipients. Ann Transplant. 2005;10(2):59-65.
31. Al-Khader AA, Suleiman M, Al-Hasani M, Haleem A. Posttransplant Kaposi sarcoma: staging as a guide to therapy and prognosis. Nephron. 1988;48(2):165.
32. Bruno B, Sorasio R, Barozzi P, et al. Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation. Eur J Haematol. 2006;76(4):342-347. (Pubitemid 43362944)
33. Marcelin AG, Roque-Afonso AM, Hurtova M, et al. Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients. Liver Transpl. 2004;10(2):295-300. (Pubitemid 38247743)
34. Francès C, Marcelin AG, Legendre CH, et al. The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival. Am J Transplant. 2009;9(11):2580-2586.
35. Gentile G, Capobianchi A, Volpi A, et al. Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients. J Natl Cancer Inst. 2005;97(13):1008-1011. (Pubitemid 41430566)
36. Porta F, Bongiorno M, Locatelli F, et al. Kaposi's sarcoma in a child after autologous bone marrow transplantation for non-Hodgkin's lymphoma. Cancer. 1991;68(6):1361-1364.
37. Helg CL, Adatto M, Salomon D, et al. Kaposi's sarcoma following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1994;14(6):999-1001.
38. Gluckman E, Parquet N, Scieux C, et al. KS-associated herpesvirus-like DNA sequences after allogeneic bone-marrow transplantation. Lancet. 1995;346(8989):1558-1559.
39. Erer B, Angelucci E, Muretto P, et al. Kaposi's sarcoma after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;19(6):629-631. (Pubitemid 27139790)
40. Vivancos P, Sarrá J, Palou J, Valls A, Garcia J, Grañena A. Kaposi's sarcoma after autologous bone marrow transplantation for multiple myeloma. Bone Marrow Transplant. 1996;17(4):669-671. (Pubitemid 26125724)
41. Tamariz-Martel R, Maldonado MS, Carrillo R, Crespo D, Pérez-Caballero C, Muñoz A. Kaposi's sarcoma after allogeneic bone marrow transplantation in a child. Haematologica. 2000;85(8):884-885.
42. de Medeiros BC, Rezuke WN, Ricci A Jr, et al. Kaposi's sarcoma following allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia. Acta Haematol. 2000;104(2):115-118. (Pubitemid 32045976)
43. Palencia SI, Rodríguez-Peralto JL, Castaño E, de la Serna J, Vanaclocha F, Iglesias-Díez L. Kaposi's sarcoma after allogeneic peripheral blood stem cell transplantation. Int J Dermatol. 2003;42(8):647-649. (Pubitemid 37025221)
44. Sala I, Faraci M, Magnano GM, et al. HHV-8- related visceral Kaposi's sarcoma following allogeneic HSCT: report of a pediatric case and literature review. Pediatr Transplant. 2011;15(1):E8-E11.
45. Jones D, Ballestas ME, Kaye KM, et al. Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Engl J Med. 1998;339(7):444-449. (Pubitemid 28377686)
46. Dotti G, Fiocchi R, Motta T, et al. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia. 1999;13(5):664-670. (Pubitemid 29243615)
47. Shaw RN, Waller EK, Offermann MK. Induction of human herpesvirus 8 gene expression in a posttransplantation primary effusion lymphoma cell line. Leuk Lymphoma. 2002;43(3):631-634. (Pubitemid 34232934)
48. Boulanger E, Afonso PV, Yahiaoui Y, Adle-Biassette H, Gabarre J, Agbalika F. Human herpesvirus-8 (HHV-8)-associated primary effusion lymphoma in two renal transplant recipients receiving rapamycin. Am J Transplant. 2008;8(3):707-710. (Pubitemid 351287542)
49. Melo NC, Sales MM, Santana AN, Costalonga EC, Pedreira AB, Ianhez LE. Pleural primary effusion lymphoma in a renal transplant recipient. Am J Transplant. 2008;8(4):906-907. (Pubitemid 351347764)
50. .Wang HY, Fuda FS, Chen W, Karandikar NJ. Notch1 in primary effusion lymphoma: a clinicopathological study. Mod Pathol. 2010;23(6):773-780.
51. Régnier-Rosencher E, Barrou B, Marcelin AG, et al. Primary effusion lymphoma in two kidney transplant recipients. Ann Dermatol Venereol. 2010;137(4):285-289.
52. Shi Y, Hou Y, Hu Q, Su J, Zeng H, Tan Y. A rare case of HHV-8-positive/HIV-negative/EBVnegative primary effusion lymphoma in a renal transplant recipient. Cytopathology. 2012;23(2):137-139.
53. Mandel C, Silberstein M, Hennessy O. Case report: fatal pulmonary Kaposi's sarcoma and Castleman's disease in a renal transplant recipient. Br J Radiol. 1993;66(783):264-265. (Pubitemid 23096982)
54. Parravicini C, Corbellino M, Paulli M, et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol. 1997;151(6):1517-1522. (Pubitemid 27527913)
55. Seckin C, Musta C. Castleman's disease in a renal transplant recipient. Nephron. 1997;76:352.
56. Cagirgan S, Cirit M, Ok E, et al. Castleman's disease in a renal allograft recipient. Nephron. 1997;76(3):352-353. (Pubitemid 27296541)
57. Theate I, Michaux L, Squifflet JP, Martin A, Raphael M. Human herpesvirus 8 and Epstein-Barr virus-related monotypic large B-cell lymphoproliferative disorder coexisting with mixed variant of Castleman's disease in a lymph node of a renal transplant recipient. Clin Transplant. 2003;17(5):451-454. (Pubitemid 37236119)
58. Gaitonde S, Vidanovic V, Ni H. Concomitant and fatal HHV-8+ multicentric Castleman's disease and Kaposi's sarcoma in the same lymph node of an HIV- liver transplant patient. Histopathology. 2007;50(7):954-958.
59. Al Otaibi T, Al Sagheir A, Ludwin D, Meyer R. Post renal transplant Castleman's disease resolved after graft nephrectomy: a case report. Transplant Proc. 2007;39(4):1276-1277. (Pubitemid 46764896)
60. Bonatti HJ, Axt J, Hunter EB, et al. Castleman disease in a pediatric liver transplant recipient: a case report and literature review. Pediatr Transplant. 2012;16(6):E229-E234.
61. Pietrosi G, Vizzini G, Pipitone L, et al. Primary and reactivated HHV8 infection and disease after liver transplantation: a prospective study. Am J Transplant. 2011;11(12):2715-2723.
62. Lim EJ, Crowley P, Mitchell CA, Angus PW. Postliver transplantation multicentric Castleman disease treated with valganciclovir and weaning of immunosuppression. Am J Transplant. 2011;11(1):169-172.
63. Matsushima AY, Strauchen JA, Lee G, et al. Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol. 1999;23(11):1393-1400. (Pubitemid 29517333)
64. Kapelushnik J, Ariad S, Benharroch D, et al. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol. 2001;113(2):425-428. (Pubitemid 32523148)
65. Luppi M, Barozzi P, Schulz TF, et al. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med. 2000;343(19):1378-1385.
66. Cuzzola M, Irrera G, Iacopino O, et al. Bone marrow failure associated with herpesvirus 8 infection in a patient undergoing autologous peripheral blood stem cell transplantation. Clin Infect Dis. 2003;37(7):e102-e106.
67. Luppi M, Barozzi P, Rasini V, et al. Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. Transplantation. 2002;74(1):131-132.
68. Luppi M, Trovato R, Barozzi P, et al. Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells. Leuk Res. 2005;29(8):951-953. (Pubitemid 40840723)
69. .Wu W, Vieira J, Fiore N, et al. KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood. 2006;108(1):141-151. (Pubitemid 43990622)
70. Kürşat S, Caǧirgan S, Ok E, et al. Haemophagocytichistiocytic syndrome in renal transplantation. Nephrol Dial Transplant. 1997;12(5):1058-1060.
71. Karras A, Thervet E, Legendre C, et al. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature. Transplantation. 2004;77(2):238-243. (Pubitemid 38155753)
72. Thaunat O, Mamzer-Bruneel MF, Agbalika F, et al. Severe human herpesvirus-8 primary infection in a renal transplant patient successfully treated with anti-CD20 monoclonal antibody. Blood. 2006;107(7):3009-3010.
73. Luppi M, Barozzi P, Schulz TF, et al. Nonmalignant disease associated with human herpesvirus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation. Blood. 2000;96(7):2355-2357.
74. Luppi M, Barozzi P, Guaraldi G, et al. Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor. Clin Infect Dis. 2003;37(4):606-607. (Pubitemid 37011788)
75. Lebbé C, Legendre C, Francès C. Kaposi sarcoma in transplantation. Transplant Rev (Orlando). 2008;22(4):252-261.
76. Serraino D, Piselli P, Scuderi M, et al. Screening for human herpesvirus 8 antibodies in Italian organ transplantation centers. Clin Infect Dis. 2005;40(1):203-205. (Pubitemid 40053483)
77. Pellet C, Chevret S, Francès C, et al. Prognostic value of quantitative Kaposi sarcoma-associated herpesvirus load in posttransplantation Kaposi sarcoma. J Infect Dis. 2002;186(1):110-113. (Pubitemid 34666922)
78. Marcelin AG, Motol J, Guihot A, et al. Relationship between the quantity of Kaposi sarcomaassociated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease. J Infect Dis. 2007;196(8):1163-1166. (Pubitemid 47580271)
79. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348(17):1681-1691. (Pubitemid 36459475)
80. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med. 2005;352(13):1317-1323. (Pubitemid 40411498)
81. Monaco AP. The role of mTOR inhibitors in the management of posttransplant malignancy. Transplantation. 2009;87(2):157-163.
82. Lambert M, Gannagé M, Karras A, et al. Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. Blood. 2006;108(12):3871-3880. (Pubitemid 44864571)
83. Barozzi P, Bonini C, Potenza L, et al. Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation. 2008;86(5):738-744.
84. Barozzi P, Potenza L, Riva G, et al. Changes in T-cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi's sarcoma in a patient with undifferentiated arthritis. Semin Arthritis Rheum. 2009;39(3):170-175.
85. Guihot A, Oksenhendler E, Galicier L, et al. Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells. Blood. 2008;111(3):1387-1395. (Pubitemid 351213425)
86. Barozzi P, Riva G, Vallerini D, et al. Indirect antitumor effects of mammalian target of rapamycin inhibitors against Kaposi sarcoma in transplant patients. Transplantation. 2009;88(4):597-598.
87. Guihot A, Dupin N, Marcelin AG, et al. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J Infect Dis. 2006;194(8):1078-1088. (Pubitemid 44547647)
88. + T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood. 2003;101(11):4290-4297.
89. Savoldo B, Rooney CM, Quiros-Tejeira RE, et al. Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease. Am J Transplant. 2005;5(3):566-572. (Pubitemid 40313349)
90. Kedes DH, Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest. 1997;99(9):2082-2086. (Pubitemid 27203763)
91. Casper C, Krantz EM, Corey L, et al. Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis. 2008;198(1):23-30. (Pubitemid 351920285)
92. Luppi M, Trovato R, Barozzi P, et al. Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir. Leukemia. 2005;19(3):473-476. (Pubitemid 40403333)
93. Lebbé C, Euvrard S, Barrou B, et al. Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transplant. 2006;6(9):2164-2168. (Pubitemid 44199551)
94. D'Amico F, Fuxman C, Nachman F, et al. Visceral Kaposi's sarcoma remission after intestinal transplant: first case report and systematic literature review. Transplantation. 2010;90(5):547-554.
95. Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev. 2003;29(5):371-387. (Pubitemid 37185104)
96. Curatolo P, Quaglino P, Marenco F, et al. Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase-II trial. Ann Surg Oncol. 2012;19(1):192-198.
97. Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 2005;106(8):2627-2632. (Pubitemid 41510733)
98. Ruozi B, Riva G, Belletti D, et al. Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma. Eur J Pharm Sci. 2010;41(2):254-264.
99. Belletti D, Riva G, Tosi G, et al. Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes. Int J Pharm. 2011;413(1-2):220-228.
100. Milone MC, Tsai DE, Hodinka RL, et al. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood. 2005;105(3):994-996. (Pubitemid 40170866)
101. Pedrazzoli P, Comoli P, Montagna D, Demirer T, Bregni M. Is adoptive T-cell therapy for solid tumors coming of age? Bone Marrow Transplant. 2012;47(8):1013-1019.